What's Happened with Endava?
Endava plc, trading under NYSE:DAVA, just got pummeled. A lawsuit is making waves, targeting investors who bought into Endava between September 2025 and 2026. What's the fuss about? Their stock tanked 25% on September 22, 2026, following an unsettling revelation: the company disclosed serious management and potential accounting problems.
A Closer Look at the Allegations
National shareholders rights firm Hagens Berman is on the hunt, rallying investors to join their cause. It's all about whether Endava violated federal securities laws. At the heart of it lies the question if Endava's financial health was honestly relayed through their reports.
Hooking in the investors, the firm won't let loose, urging them to promptly file their losses. Partners on all fronts are being invited to jump aboard and spill what they know—Hagens Berman's attorneys are lending an ear.
The Core of the Legal Battle
Zooming in, the case revolves around Endava's big talk about their financial statements being top-notch. They boasted about their pivot to AI, supposedly in full swing. But not everyone was buying it.
Allegations state that Endava didn't spill the beans on their shaky accounting practices, especially involving customer and supplier agreements, posing a potential delay in their financial reports for 2026.
Shake Up in the Executive Ranks
An unforeseen shake-up stirred the pot even more. On September 21, 2026, Endava welcomed an interim CFO. In a twist, Mark Thurston, the outgoing CFO, took an administrative leave—advised by the board after feedback from the Audit Committee.
The internal investigation spotlighted issues, triggered when external auditors flagged concerns over Endava's accounting treatment regarding certain agreements. What a mess!
Stock Market Reaction
Unsurprisingly, the market took no prisoners. Endava's stock plummeted by over 25% the day the CFO change was dropped and assurance faltered. Investors felt the jolt as trust nosedived.
"We're focused on whether Endava may have to restate its historical financial statements and, if so, whether the adjustments implicate the company's claims that its AI pivot was gaining momentum," commented Reed Kathrein, the Hagens Berman partner spearheading the investigation.
The Clock is Ticking for Investors
If you owned Endava shares and took a hit, or if you hold critical information, Hagens Berman is urging you to step forward and make it count before the November 30, 2026 deadline.
- Shareholders bearing significant losses have a vested interest in this legal pursuit.
- Whistleblowers can potentially benefit from award incentives—up to 30% of SEC recoveries.
Meet Hagens Berman
This isn't Hagens Berman's first rodeo. They're a powerhouse in shareholder litigation, reeling in over $2.9 billion in settlements. They call the shots in complex litigation across the globe, championing accountability.
Find more about Hagens Berman's track record at hbsslaw.com. Keep abreast of updates on this case and others by following them on social media.
